A research team’s part in a special trial into COVID-19 treatments has been highlighted after three members were recognised.
The team have been at the forefront of the national trial – testing various potential treatments for the coronavirus.
The organisation’s many achievements have included being the first testing site in the country to trial three different treatments.
The research team has also been the second highest recruiter of patients in the UK – taking on just under 800 people.
All three have been presented with a certificate of recognition for their “outstanding contribution to research” by the National Institute of Health Research regional Clinical Research Network.
Ben said: “The recognition which Alex, Rachel and I have received is testament to the outstanding work the whole research team and supporting staff have given to this study.
“We have gone above and beyond in our work, been among the highest recruiters of patients in the country and have been the first to trial three new treatments.
“It’s a fantastic achievement by the whole organisation and we are so proud to have made such a difference to people’s lives.”
Dr Prudon’s nomination highlighted his leadership, passion for research and his relationship with patients involved.
Alex’s mentioned her enthusiasm and energy and her achievement in being appointed the study’s lead research mid-way through the trial.
Rachel’s nomination included details about her work developing screening logs and setting up an effective IT system to find potential patients to recruit.